

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maturation of SSU-rRNA (GO:0030490) | 6.37481896 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.04051959 |
| 3 | DNA deamination (GO:0045006) | 5.89216998 |
| 4 | viral transcription (GO:0019083) | 5.83074123 |
| 5 | translational termination (GO:0006415) | 5.64172999 |
| 6 | translational elongation (GO:0006414) | 4.97391580 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.86365810 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.83029752 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 4.74312460 |
| 10 | protein targeting to ER (GO:0045047) | 4.71140295 |
| 11 | translational initiation (GO:0006413) | 4.61721797 |
| 12 | ribosomal large subunit biogenesis (GO:0042273) | 4.57697014 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.50569231 |
| 14 | GDP-mannose metabolic process (GO:0019673) | 4.50365515 |
| 15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.45090514 |
| 16 | protein localization to endoplasmic reticulum (GO:0070972) | 4.42686249 |
| 17 | viral life cycle (GO:0019058) | 4.37218262 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.31062268 |
| 19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.27469833 |
| 20 | mannose metabolic process (GO:0006013) | 4.23552675 |
| 21 | regulation of mitochondrial translation (GO:0070129) | 4.13658775 |
| 22 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.08710886 |
| 23 | formation of translation preinitiation complex (GO:0001731) | 3.85619660 |
| 24 | NIK/NF-kappaB signaling (GO:0038061) | 3.85605901 |
| 25 | protein complex disassembly (GO:0043241) | 3.82751973 |
| 26 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.79407690 |
| 27 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.75013029 |
| 28 | translation (GO:0006412) | 3.70324133 |
| 29 | macromolecular complex disassembly (GO:0032984) | 3.66146446 |
| 30 | rRNA modification (GO:0000154) | 3.65530764 |
| 31 | rRNA processing (GO:0006364) | 3.60695337 |
| 32 | pseudouridine synthesis (GO:0001522) | 3.56940496 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.56468900 |
| 34 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.54044682 |
| 35 | mature B cell differentiation involved in immune response (GO:0002313) | 3.48407122 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47873974 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47873974 |
| 38 | response to peptidoglycan (GO:0032494) | 3.47225485 |
| 39 | rRNA metabolic process (GO:0016072) | 3.46475105 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.42539791 |
| 41 | termination of RNA polymerase III transcription (GO:0006386) | 3.39472006 |
| 42 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.39472006 |
| 43 | cellular response to virus (GO:0098586) | 3.35606943 |
| 44 | mRNA catabolic process (GO:0006402) | 3.34526519 |
| 45 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.33393382 |
| 46 | amino sugar catabolic process (GO:0046348) | 3.33318033 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.32515061 |
| 48 | cellular component biogenesis (GO:0044085) | 3.28853916 |
| 49 | response to protozoan (GO:0001562) | 3.24927959 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.23116206 |
| 51 | response to type I interferon (GO:0034340) | 3.22360603 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18889285 |
| 53 | negative regulation of cell killing (GO:0031342) | 3.18889285 |
| 54 | RNA catabolic process (GO:0006401) | 3.17153676 |
| 55 | modulation by symbiont of host cellular process (GO:0044068) | 3.15217957 |
| 56 | intra-S DNA damage checkpoint (GO:0031573) | 3.14572813 |
| 57 | response to muramyl dipeptide (GO:0032495) | 3.14274484 |
| 58 | spliceosomal snRNP assembly (GO:0000387) | 3.12597070 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12416394 |
| 60 | defense response to protozoan (GO:0042832) | 3.11903518 |
| 61 | protein targeting to membrane (GO:0006612) | 3.11344185 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11249134 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.11156785 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.11156785 |
| 65 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.11026788 |
| 66 | N-acetylneuraminate metabolic process (GO:0006054) | 3.10327688 |
| 67 | rRNA methylation (GO:0031167) | 3.09775465 |
| 68 | protein complex biogenesis (GO:0070271) | 3.09664106 |
| 69 | germinal center formation (GO:0002467) | 3.09051046 |
| 70 | proteasome assembly (GO:0043248) | 3.08099555 |
| 71 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.07259437 |
| 72 | ribosome biogenesis (GO:0042254) | 3.05536344 |
| 73 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.04276540 |
| 74 | modulation by virus of host process (GO:0019054) | 3.03575896 |
| 75 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.03480481 |
| 76 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.03151418 |
| 77 | tRNA methylation (GO:0030488) | 3.02665552 |
| 78 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.02217937 |
| 79 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.00652764 |
| 80 | negative regulation of ligase activity (GO:0051352) | 3.00652764 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.99905392 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.99399367 |
| 83 | negative regulation of RNA splicing (GO:0033119) | 2.98944940 |
| 84 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.98563904 |
| 85 | mature B cell differentiation (GO:0002335) | 2.98540694 |
| 86 | cellular response to exogenous dsRNA (GO:0071360) | 2.97867794 |
| 87 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.95543940 |
| 88 | cytochrome complex assembly (GO:0017004) | 2.95434311 |
| 89 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.92223505 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92084013 |
| 91 | pyrimidine nucleoside salvage (GO:0043097) | 2.91657710 |
| 92 | pyrimidine-containing compound salvage (GO:0008655) | 2.91657710 |
| 93 | DNA strand elongation (GO:0022616) | 2.89726964 |
| 94 | nucleobase biosynthetic process (GO:0046112) | 2.89660969 |
| 95 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.89124393 |
| 96 | UV protection (GO:0009650) | 2.88487584 |
| 97 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.88295114 |
| 98 | metallo-sulfur cluster assembly (GO:0031163) | 2.88030397 |
| 99 | iron-sulfur cluster assembly (GO:0016226) | 2.88030397 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 2.87843398 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.87843398 |
| 102 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87404226 |
| 103 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.86905393 |
| 104 | myeloid dendritic cell differentiation (GO:0043011) | 2.86269053 |
| 105 | negative regulation of viral release from host cell (GO:1902187) | 2.84272892 |
| 106 | activation of MAPKKK activity (GO:0000185) | 2.83880088 |
| 107 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83836272 |
| 108 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.83217586 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.82474991 |
| 110 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82068418 |
| 111 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82068418 |
| 112 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82068418 |
| 113 | ncRNA processing (GO:0034470) | 2.81013896 |
| 114 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80848382 |
| 115 | macrophage activation involved in immune response (GO:0002281) | 2.79764367 |
| 116 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78828112 |
| 117 | positive regulation of histone deacetylation (GO:0031065) | 2.77578848 |
| 118 | ncRNA 3-end processing (GO:0043628) | 2.77190082 |
| 119 | negative regulation of innate immune response (GO:0045824) | 2.76901206 |
| 120 | protein targeting to mitochondrion (GO:0006626) | 2.76304291 |
| 121 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.75972224 |
| 122 | positive regulation of protein kinase C signaling (GO:0090037) | 2.75736649 |
| 123 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.75139270 |
| 124 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.75139270 |
| 125 | autophagic vacuole fusion (GO:0000046) | 2.75012828 |
| 126 | telomere maintenance via recombination (GO:0000722) | 2.74985958 |
| 127 | cellular response to interferon-beta (GO:0035458) | 2.72609805 |
| 128 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.71966687 |
| 129 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.71966687 |
| 130 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.71966687 |
| 131 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70730334 |
| 132 | purine nucleobase biosynthetic process (GO:0009113) | 2.70173977 |
| 133 | DNA replication checkpoint (GO:0000076) | 2.69652280 |
| 134 | RNA methylation (GO:0001510) | 2.69337661 |
| 135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.68974755 |
| 136 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.68188002 |
| 137 | regulation of gamma-delta T cell activation (GO:0046643) | 2.68172227 |
| 138 | adenosine receptor signaling pathway (GO:0001973) | 2.67501239 |
| 139 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.66928918 |
| 140 | positive thymic T cell selection (GO:0045059) | 2.66846001 |
| 141 | peptidyl-histidine modification (GO:0018202) | 2.65964533 |
| 142 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.65742360 |
| 143 | positive regulation of defense response to virus by host (GO:0002230) | 2.65482693 |
| 144 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.65419834 |
| 145 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.65419834 |
| 146 | histone mRNA metabolic process (GO:0008334) | 2.64886815 |
| 147 | oxidative phosphorylation (GO:0006119) | 2.64689981 |
| 148 | respiratory chain complex IV assembly (GO:0008535) | 2.64262647 |
| 149 | low-density lipoprotein particle clearance (GO:0034383) | 2.63785350 |
| 150 | positive regulation of B cell differentiation (GO:0045579) | 2.63368364 |
| 151 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.63229614 |
| 152 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60641539 |
| 153 | regulation of chemokine biosynthetic process (GO:0045073) | 2.60314097 |
| 154 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.59759731 |
| 155 | T cell lineage commitment (GO:0002360) | 2.56661719 |
| 156 | nucleotide salvage (GO:0043173) | 2.55689791 |
| 157 | pinocytosis (GO:0006907) | 2.55432398 |
| 158 | immunoglobulin mediated immune response (GO:0016064) | 2.54635127 |
| 159 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.54486260 |
| 160 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.54482483 |
| 161 | regulation of necrotic cell death (GO:0010939) | 2.53671200 |
| 162 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52577964 |
| 163 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.52348062 |
| 164 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.52023516 |
| 165 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.50424622 |
| 166 | glycosphingolipid catabolic process (GO:0046479) | 2.49592705 |
| 167 | regulation of tumor necrosis factor production (GO:0032680) | 2.48613700 |
| 168 | myeloid dendritic cell activation (GO:0001773) | 2.48356799 |
| 169 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.48221063 |
| 170 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.47369505 |
| 171 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.46504195 |
| 172 | positive regulation of protein deacetylation (GO:0090312) | 2.45963306 |
| 173 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45879240 |
| 174 | regulation of viral release from host cell (GO:1902186) | 2.45618653 |
| 175 | regulation of defense response to virus by host (GO:0050691) | 2.43860630 |
| 176 | regulation of necroptotic process (GO:0060544) | 2.42786255 |
| 177 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.42203333 |
| 178 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.41509396 |
| 179 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41509396 |
| 180 | modulation by symbiont of host immune response (GO:0052553) | 2.41509396 |
| 181 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41509396 |
| 182 | modulation by symbiont of host defense response (GO:0052031) | 2.41509396 |
| 183 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41509396 |
| 184 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.40931848 |
| 185 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.37087475 |
| 186 | regulation of interferon-alpha production (GO:0032647) | 2.36821993 |
| 187 | barbed-end actin filament capping (GO:0051016) | 2.34283128 |
| 188 | protein localization to endosome (GO:0036010) | 2.33477440 |
| 189 | positive regulation of antigen processing and presentation (GO:0002579) | 2.32937938 |
| 190 | purinergic receptor signaling pathway (GO:0035587) | 2.32791387 |
| 191 | regulation of antigen processing and presentation (GO:0002577) | 2.32467155 |
| 192 | regulation of mast cell degranulation (GO:0043304) | 2.32308950 |
| 193 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.31989047 |
| 194 | negative regulation of cell size (GO:0045792) | 2.31292307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.23649373 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.15974644 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.85494567 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.56112541 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.40043599 |
| 6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.20237672 |
| 7 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.19737070 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.14552394 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.07080885 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.03812176 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.92933438 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.92845892 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84072831 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.80568331 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.79990180 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.70473905 |
| 17 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.65185812 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.54489038 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.54350104 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52798079 |
| 21 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.46681957 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33282227 |
| 23 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.32455473 |
| 24 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.28932009 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25838318 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 2.25729655 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25189509 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22995572 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.17827062 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.17621583 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.14009580 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.08394476 |
| 33 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.06329186 |
| 34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.06043214 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.04677243 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02813417 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 2.01566677 |
| 38 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.98517460 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.97325986 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96942412 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.96828763 |
| 42 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.96291289 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.95981236 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94719842 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.94330729 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.94221132 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92933132 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89648170 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.87905481 |
| 50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.87833023 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85619936 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.84714020 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.84657430 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.84647984 |
| 55 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.82862637 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82597723 |
| 57 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79635704 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79234326 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75777385 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70179358 |
| 61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67578236 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.66529629 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.66376612 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65374277 |
| 65 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62204076 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58612436 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56967893 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56702972 |
| 69 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56220945 |
| 70 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55229927 |
| 71 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54984412 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54597623 |
| 73 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54265827 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53175101 |
| 75 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.52146006 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51756436 |
| 77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.49562715 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.45095041 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43106851 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41622305 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41527387 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41419723 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.41346901 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39584817 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39219401 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39150131 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38515338 |
| 88 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38471711 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.37982888 |
| 90 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36775452 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.36377682 |
| 92 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.35059659 |
| 93 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.33947338 |
| 94 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33733060 |
| 95 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.33638029 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.33109545 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32997740 |
| 98 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32417602 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.31978299 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31941067 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31635133 |
| 102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30467597 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30326970 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30168144 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30008225 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.29858680 |
| 107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29609252 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29310371 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28960962 |
| 110 | MYB_26560356_Chip-Seq_TH2_Human | 1.28935727 |
| 111 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.27913585 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27181412 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26182271 |
| 114 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24483882 |
| 115 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.24183508 |
| 116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23259403 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23006258 |
| 118 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22805462 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22003647 |
| 120 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21834746 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21703117 |
| 122 | SA1_27219007_Chip-Seq_Bcells_Human | 1.19511593 |
| 123 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.18854357 |
| 124 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18235040 |
| 125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18049444 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16327875 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16185566 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 1.15437029 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14606267 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13916154 |
| 131 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.13710335 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13699349 |
| 133 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13561888 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13408075 |
| 135 | MYB_26560356_Chip-Seq_TH1_Human | 1.13158258 |
| 136 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13121262 |
| 137 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.12803433 |
| 138 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12676557 |
| 139 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11968083 |
| 140 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11908992 |
| 141 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11792715 |
| 142 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.11485720 |
| 143 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11332214 |
| 144 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10013196 |
| 145 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09665549 |
| 146 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09384453 |
| 147 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08937298 |
| 148 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07694162 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07348904 |
| 150 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07325823 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06551209 |
| 152 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06496619 |
| 153 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06438770 |
| 154 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06254068 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05584031 |
| 156 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.05461420 |
| 157 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05258146 |
| 158 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05248330 |
| 159 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04523974 |
| 160 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03249878 |
| 161 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02642104 |
| 162 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01933497 |
| 163 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99993232 |
| 164 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97487038 |
| 165 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97481905 |
| 166 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96132713 |
| 167 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94880655 |
| 168 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93991910 |
| 169 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93090775 |
| 170 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.92634917 |
| 171 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91816995 |
| 172 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90173491 |
| 173 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90066126 |
| 174 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89612569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.93152118 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.57304492 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.41372273 |
| 4 | MP0005671_abnormal_response_to | 3.40050223 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.37705450 |
| 6 | MP0005451_abnormal_body_composition | 3.07378998 |
| 7 | MP0000685_abnormal_immune_system | 2.98193443 |
| 8 | MP0009840_abnormal_foam_cell | 2.92995264 |
| 9 | MP0008058_abnormal_DNA_repair | 2.62183961 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.47179367 |
| 11 | MP0002398_abnormal_bone_marrow | 2.43604767 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.41894850 |
| 13 | MP0001800_abnormal_humoral_immune | 2.39685827 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 2.36058512 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.32279864 |
| 16 | MP0010094_abnormal_chromosome_stability | 2.27953119 |
| 17 | MP0003077_abnormal_cell_cycle | 2.23078614 |
| 18 | MP0006082_CNS_inflammation | 2.21420704 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.12983083 |
| 20 | MP0002132_abnormal_respiratory_system | 2.12517976 |
| 21 | MP0009278_abnormal_bone_marrow | 2.12510200 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.08726806 |
| 23 | MP0001819_abnormal_immune_cell | 2.08546854 |
| 24 | MP0005083_abnormal_biliary_tract | 2.07182225 |
| 25 | MP0001853_heart_inflammation | 2.06678876 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.05388706 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.04866230 |
| 28 | MP0003436_decreased_susceptibility_to | 2.02671214 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 2.01961424 |
| 30 | MP0002723_abnormal_immune_serum | 2.00820129 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.99485265 |
| 32 | MP0003646_muscle_fatigue | 1.99391029 |
| 33 | MP0000716_abnormal_immune_system | 1.97376323 |
| 34 | MP0002722_abnormal_immune_system | 1.97349363 |
| 35 | MP0002452_abnormal_antigen_presenting | 1.95235660 |
| 36 | MP0009785_altered_susceptibility_to | 1.95191418 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.89618582 |
| 38 | MP0003453_abnormal_keratinocyte_physiol | 1.87025709 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.85977150 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.84943806 |
| 41 | MP0005025_abnormal_response_to | 1.84188445 |
| 42 | MP0002429_abnormal_blood_cell | 1.83447415 |
| 43 | MP0005387_immune_system_phenotype | 1.79223758 |
| 44 | MP0001790_abnormal_immune_system | 1.79223758 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.78846303 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.78673920 |
| 47 | MP0008057_abnormal_DNA_replication | 1.72279474 |
| 48 | MP0003866_abnormal_defecation | 1.64441532 |
| 49 | MP0000490_abnormal_crypts_of | 1.62187184 |
| 50 | MP0009764_decreased_sensitivity_to | 1.62166676 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.58566906 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.51982984 |
| 53 | MP0003724_increased_susceptibility_to | 1.50951945 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.40099100 |
| 55 | MP0002405_respiratory_system_inflammati | 1.37711425 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.36460670 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.36283971 |
| 58 | MP0001873_stomach_inflammation | 1.35586257 |
| 59 | MP0005310_abnormal_salivary_gland | 1.34285634 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.34008290 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.29851115 |
| 62 | MP0000858_altered_metastatic_potential | 1.29638416 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.29607273 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.28437631 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.28180223 |
| 66 | MP0003329_amyloid_beta_deposits | 1.27656962 |
| 67 | MP0000604_amyloidosis | 1.26829669 |
| 68 | MP0002166_altered_tumor_susceptibility | 1.26498332 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.24063948 |
| 70 | MP0003075_altered_response_to | 1.23539141 |
| 71 | MP0000343_altered_response_to | 1.23176657 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.22117368 |
| 73 | MP0002419_abnormal_innate_immunity | 1.19401649 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.18063855 |
| 75 | MP0004043_abnormal_pH_regulation | 1.18057767 |
| 76 | MP0010155_abnormal_intestine_physiology | 1.17821968 |
| 77 | MP0000750_abnormal_muscle_regeneration | 1.17186991 |
| 78 | MP0000313_abnormal_cell_death | 1.17136685 |
| 79 | MP0005360_urolithiasis | 1.14752068 |
| 80 | MP0008932_abnormal_embryonic_tissue | 1.13768540 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.13342207 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.13342207 |
| 83 | MP0002163_abnormal_gland_morphology | 1.13193804 |
| 84 | MP0004215_abnormal_myocardial_fiber | 1.12907427 |
| 85 | MP0002095_abnormal_skin_pigmentation | 1.11306706 |
| 86 | MP0001849_ear_inflammation | 1.10566596 |
| 87 | MP0002332_abnormal_exercise_endurance | 1.10326285 |
| 88 | MP0003300_gastrointestinal_ulcer | 1.10193100 |
| 89 | MP0002638_abnormal_pupillary_reflex | 1.10030679 |
| 90 | MP0004036_abnormal_muscle_relaxation | 1.09834031 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.08125972 |
| 92 | MP0003303_peritoneal_inflammation | 1.07440772 |
| 93 | MP0005375_adipose_tissue_phenotype | 1.04703807 |
| 94 | MP0001845_abnormal_inflammatory_respons | 1.04166651 |
| 95 | MP0006292_abnormal_olfactory_placode | 1.03824774 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.02586427 |
| 97 | MP0005464_abnormal_platelet_physiology | 1.02419207 |
| 98 | MP0002254_reproductive_system_inflammat | 1.02209555 |
| 99 | MP0000749_muscle_degeneration | 1.01849859 |
| 100 | MP0003786_premature_aging | 1.00275599 |
| 101 | MP0000358_abnormal_cell_content/ | 0.99284355 |
| 102 | MP0002006_tumorigenesis | 0.99023701 |
| 103 | MP0004147_increased_porphyrin_level | 0.98769772 |
| 104 | MP0005166_decreased_susceptibility_to | 0.97712314 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.96624090 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 0.96307191 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96169259 |
| 108 | MP0000350_abnormal_cell_proliferation | 0.95996765 |
| 109 | MP0005365_abnormal_bile_salt | 0.95112776 |
| 110 | MP0004130_abnormal_muscle_cell | 0.91668148 |
| 111 | MP0002933_joint_inflammation | 0.91424950 |
| 112 | MP0004858_abnormal_nervous_system | 0.89949608 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.87668525 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.87666617 |
| 115 | MP0008469_abnormal_protein_level | 0.86628307 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.86020781 |
| 117 | MP0000751_myopathy | 0.85720778 |
| 118 | MP0004381_abnormal_hair_follicle | 0.84803464 |
| 119 | MP0005023_abnormal_wound_healing | 0.84413739 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.84144361 |
| 121 | MP0000747_muscle_weakness | 0.84048817 |
| 122 | MP0003279_aneurysm | 0.83780963 |
| 123 | MP0008874_decreased_physiological_sensi | 0.83514305 |
| 124 | MP0003091_abnormal_cell_migration | 0.81952954 |
| 125 | MP0001958_emphysema | 0.81573221 |
| 126 | MP0002139_abnormal_hepatobiliary_system | 0.80148132 |
| 127 | MP0001986_abnormal_taste_sensitivity | 0.79184879 |
| 128 | * MP0002080_prenatal_lethality | 0.78252095 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.78114516 |
| 130 | MP0005390_skeleton_phenotype | 0.77743518 |
| 131 | MP0001730_embryonic_growth_arrest | 0.74547488 |
| 132 | MP0000609_abnormal_liver_physiology | 0.74464588 |
| 133 | MP0004510_myositis | 0.73998918 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.72880731 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.71452601 |
| 136 | MP0005330_cardiomyopathy | 0.71230198 |
| 137 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70339292 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67845112 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.66846863 |
| 140 | MP0002277_abnormal_respiratory_mucosa | 0.66699071 |
| 141 | MP0003123_paternal_imprinting | 0.66482603 |
| 142 | MP0001697_abnormal_embryo_size | 0.65531851 |
| 143 | MP0004947_skin_inflammation | 0.65046410 |
| 144 | MP0008260_abnormal_autophagy | 0.62685259 |
| 145 | MP0003315_abnormal_perineum_morphology | 0.61441320 |
| 146 | MP0005670_abnormal_white_adipose | 0.61351271 |
| 147 | MP0002106_abnormal_muscle_physiology | 0.60772258 |
| 148 | MP0001533_abnormal_skeleton_physiology | 0.59775331 |
| 149 | MP0001663_abnormal_digestive_system | 0.57868393 |
| 150 | MP0003828_pulmonary_edema | 0.57318041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.05963858 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.93362759 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.84040267 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.84040267 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.84040267 |
| 6 | Aplastic anemia (HP:0001915) | 4.37175313 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.22418800 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.18902914 |
| 9 | Reticulocytopenia (HP:0001896) | 3.91351982 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.88558550 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.86450922 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.84645294 |
| 13 | Hepatic necrosis (HP:0002605) | 3.80936698 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.71460416 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.68559270 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.67626980 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.67626980 |
| 18 | IgM deficiency (HP:0002850) | 3.65769104 |
| 19 | Increased CSF lactate (HP:0002490) | 3.64233491 |
| 20 | Macrocytic anemia (HP:0001972) | 3.57777171 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47421093 |
| 22 | Thrombocytosis (HP:0001894) | 3.46520788 |
| 23 | Pallor (HP:0000980) | 3.42466395 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.41792201 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.41792201 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.41792201 |
| 27 | Abnormality of alanine metabolism (HP:0010916) | 3.17588362 |
| 28 | Hyperalaninemia (HP:0003348) | 3.17588362 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.17588362 |
| 30 | Acute encephalopathy (HP:0006846) | 3.13521990 |
| 31 | Increased serum lactate (HP:0002151) | 3.12878211 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 3.11390131 |
| 33 | Hemorrhage of the eye (HP:0011885) | 3.10498318 |
| 34 | Increased serum ferritin (HP:0003281) | 3.08235003 |
| 35 | Mucopolysacchariduria (HP:0008155) | 3.05997987 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.05997987 |
| 37 | Abnormality of B cell number (HP:0010975) | 3.03954515 |
| 38 | B lymphocytopenia (HP:0010976) | 3.03954515 |
| 39 | Abnormality of macrophages (HP:0004311) | 3.01086595 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.97522141 |
| 41 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95114300 |
| 42 | Lactic acidosis (HP:0003128) | 2.94476704 |
| 43 | Thin bony cortex (HP:0002753) | 2.92214164 |
| 44 | Progressive macrocephaly (HP:0004481) | 2.90329659 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.90066384 |
| 46 | IgG deficiency (HP:0004315) | 2.87208785 |
| 47 | Colitis (HP:0002583) | 2.86347612 |
| 48 | Oral leukoplakia (HP:0002745) | 2.85444482 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.83952112 |
| 50 | Loss of speech (HP:0002371) | 2.82654717 |
| 51 | Respiratory difficulties (HP:0002880) | 2.82537140 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.81529972 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.78411918 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.73881468 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.71313814 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.68591542 |
| 57 | Colon cancer (HP:0003003) | 2.68013452 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.64796188 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.64511364 |
| 60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61700910 |
| 61 | Pustule (HP:0200039) | 2.59806852 |
| 62 | Chronic otitis media (HP:0000389) | 2.59253679 |
| 63 | Pancytopenia (HP:0001876) | 2.58150260 |
| 64 | Exertional dyspnea (HP:0002875) | 2.58143285 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.57571998 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.53206743 |
| 67 | Abnormality of T cells (HP:0002843) | 2.53126992 |
| 68 | Respiratory failure (HP:0002878) | 2.51034190 |
| 69 | Orchitis (HP:0100796) | 2.48667928 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.47632663 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.46444025 |
| 72 | Exercise intolerance (HP:0003546) | 2.46418178 |
| 73 | Multiple enchondromatosis (HP:0005701) | 2.45350868 |
| 74 | Increased muscle lipid content (HP:0009058) | 2.45340043 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.43534418 |
| 76 | Abnormal protein glycosylation (HP:0012346) | 2.43534418 |
| 77 | Abnormal glycosylation (HP:0012345) | 2.43534418 |
| 78 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.43534418 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 2.41571848 |
| 80 | Upper limb amyotrophy (HP:0009129) | 2.41571848 |
| 81 | Malnutrition (HP:0004395) | 2.41163108 |
| 82 | Purpura (HP:0000979) | 2.40468787 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.39342064 |
| 84 | Emotional lability (HP:0000712) | 2.39235289 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 2.39079739 |
| 86 | Prolonged neonatal jaundice (HP:0006579) | 2.38186554 |
| 87 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.37084464 |
| 88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.36368283 |
| 89 | Gastrointestinal stroma tumor (HP:0100723) | 2.35392312 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.33676772 |
| 91 | J-shaped sella turcica (HP:0002680) | 2.31522699 |
| 92 | Cerebral hypomyelination (HP:0006808) | 2.29490964 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.28382318 |
| 94 | Lymphoma (HP:0002665) | 2.27956737 |
| 95 | Testicular atrophy (HP:0000029) | 2.27282169 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 2.23623238 |
| 97 | Muscle fiber atrophy (HP:0100295) | 2.22301260 |
| 98 | Axonal loss (HP:0003447) | 2.21226189 |
| 99 | Achilles tendon contracture (HP:0001771) | 2.20515205 |
| 100 | Myositis (HP:0100614) | 2.19735971 |
| 101 | Rough bone trabeculation (HP:0100670) | 2.19610792 |
| 102 | Vertebral compression fractures (HP:0002953) | 2.19091813 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 2.18395702 |
| 104 | Nasal polyposis (HP:0100582) | 2.18066693 |
| 105 | Hypertriglyceridemia (HP:0002155) | 2.17832284 |
| 106 | Hypertensive crisis (HP:0100735) | 2.13725109 |
| 107 | Inflammation of the large intestine (HP:0002037) | 2.13717775 |
| 108 | Lymphopenia (HP:0001888) | 2.13507683 |
| 109 | Nuclear cataract (HP:0100018) | 2.12599682 |
| 110 | T lymphocytopenia (HP:0005403) | 2.12476979 |
| 111 | Cellulitis (HP:0100658) | 2.12037645 |
| 112 | Poikiloderma (HP:0001029) | 2.11458800 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.10073496 |
| 114 | Stridor (HP:0010307) | 2.09979519 |
| 115 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09776431 |
| 116 | Gastrointestinal infarctions (HP:0005244) | 2.09587275 |
| 117 | Severe visual impairment (HP:0001141) | 2.09321901 |
| 118 | Autoimmune thrombocytopenia (HP:0001973) | 2.08272799 |
| 119 | Obstructive lung disease (HP:0006536) | 2.08259236 |
| 120 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08259236 |
| 121 | Abnormality of glycolysis (HP:0004366) | 2.07243970 |
| 122 | Increased serum pyruvate (HP:0003542) | 2.07243970 |
| 123 | Mesangial abnormality (HP:0001966) | 2.06414792 |
| 124 | Retrobulbar optic neuritis (HP:0100654) | 2.05366590 |
| 125 | Optic neuritis (HP:0100653) | 2.05366590 |
| 126 | Joint stiffness (HP:0001387) | 2.05338530 |
| 127 | Recurrent viral infections (HP:0004429) | 2.04037866 |
| 128 | Squamous cell carcinoma (HP:0002860) | 2.03458793 |
| 129 | Increased connective tissue (HP:0009025) | 2.03414566 |
| 130 | Difficulty climbing stairs (HP:0003551) | 2.02106521 |
| 131 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01080385 |
| 132 | Myopathic facies (HP:0002058) | 2.00778000 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 2.00268878 |
| 134 | CNS demyelination (HP:0007305) | 1.99861023 |
| 135 | Abnormality of T cell number (HP:0011839) | 1.96264331 |
| 136 | Stomatitis (HP:0010280) | 1.96249129 |
| 137 | Amaurosis fugax (HP:0100576) | 1.95287048 |
| 138 | Type 2 muscle fiber atrophy (HP:0003554) | 1.95156032 |
| 139 | Abnormality of the Achilles tendon (HP:0005109) | 1.95086900 |
| 140 | Severe combined immunodeficiency (HP:0004430) | 1.94828877 |
| 141 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.94195484 |
| 142 | Recurrent cutaneous fungal infections (HP:0011370) | 1.94195484 |
| 143 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93950587 |
| 144 | Premature graying of hair (HP:0002216) | 1.92304587 |
| 145 | Cerebral edema (HP:0002181) | 1.92237272 |
| 146 | Emphysema (HP:0002097) | 1.91905572 |
| 147 | Gastrointestinal dysmotility (HP:0002579) | 1.91106008 |
| 148 | Neutropenia (HP:0001875) | 1.90493716 |
| 149 | Ulnar bowing (HP:0003031) | 1.90128140 |
| 150 | Meningitis (HP:0001287) | 1.88252482 |
| 151 | Progressive neurologic deterioration (HP:0002344) | 1.87243594 |
| 152 | Recurrent skin infections (HP:0001581) | 1.86959933 |
| 153 | Prolonged bleeding time (HP:0003010) | 1.86938992 |
| 154 | Hypoplasia of the thymus (HP:0000778) | 1.86218152 |
| 155 | Recurrent fungal infections (HP:0002841) | 1.84337203 |
| 156 | Asymmetric septal hypertrophy (HP:0001670) | 1.82892220 |
| 157 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82528772 |
| 158 | Renal Fanconi syndrome (HP:0001994) | 1.82423021 |
| 159 | Amyloidosis (HP:0011034) | 1.82142071 |
| 160 | Neurofibrillary tangles (HP:0002185) | 1.81750842 |
| 161 | Mediastinal lymphadenopathy (HP:0100721) | 1.80502166 |
| 162 | Optic disc pallor (HP:0000543) | 1.79726662 |
| 163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79201760 |
| 164 | Hyperacusis (HP:0010780) | 1.79139904 |
| 165 | Microretrognathia (HP:0000308) | 1.78268824 |
| 166 | Petechiae (HP:0000967) | 1.78112194 |
| 167 | Birth length less than 3rd percentile (HP:0003561) | 1.77347531 |
| 168 | Abnormality of eosinophils (HP:0001879) | 1.77249517 |
| 169 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75701953 |
| 170 | Gastrointestinal inflammation (HP:0004386) | 1.75236608 |
| 171 | Cheilitis (HP:0100825) | 1.75117144 |
| 172 | Increased IgE level (HP:0003212) | 1.75078667 |
| 173 | Epistaxis (HP:0000421) | 1.74610002 |
| 174 | Broad face (HP:0000283) | 1.74397654 |
| 175 | IgA deficiency (HP:0002720) | 1.72644907 |
| 176 | Opisthotonus (HP:0002179) | 1.72474787 |
| 177 | Encephalitis (HP:0002383) | 1.72178472 |
| 178 | Progressive microcephaly (HP:0000253) | 1.72083559 |
| 179 | Flat occiput (HP:0005469) | 1.71346095 |
| 180 | Visual hallucinations (HP:0002367) | 1.69818542 |
| 181 | Hepatosplenomegaly (HP:0001433) | 1.69362015 |
| 182 | Supranuclear gaze palsy (HP:0000605) | 1.67759980 |
| 183 | Distal lower limb muscle weakness (HP:0009053) | 1.67421709 |
| 184 | Thoracic kyphosis (HP:0002942) | 1.67406828 |
| 185 | Akinesia (HP:0002304) | 1.66437818 |
| 186 | Xanthomatosis (HP:0000991) | 1.65295387 |
| 187 | Cerebral inclusion bodies (HP:0100314) | 1.64477958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 4.77613961 |
| 2 | TLK1 | 3.53396487 |
| 3 | TRIB3 | 3.52356815 |
| 4 | NME2 | 3.49527719 |
| 5 | MAP4K1 | 3.10963759 |
| 6 | BUB1 | 3.05722618 |
| 7 | STK16 | 2.89103751 |
| 8 | DYRK3 | 2.76838596 |
| 9 | WEE1 | 2.58231814 |
| 10 | ACVR1B | 2.54179646 |
| 11 | PIM2 | 2.15522363 |
| 12 | KDR | 2.14445351 |
| 13 | TAOK2 | 1.97057608 |
| 14 | TESK2 | 1.95695683 |
| 15 | SIK1 | 1.95219248 |
| 16 | BCKDK | 1.94714123 |
| 17 | MAP3K10 | 1.92249387 |
| 18 | EPHA2 | 1.90302607 |
| 19 | ZAP70 | 1.85790153 |
| 20 | PRPF4B | 1.83017129 |
| 21 | SMG1 | 1.71435394 |
| 22 | ICK | 1.70212955 |
| 23 | TXK | 1.64325843 |
| 24 | MST1R | 1.63330691 |
| 25 | NME1 | 1.61359213 |
| 26 | SRPK1 | 1.57953832 |
| 27 | RPS6KA4 | 1.51757778 |
| 28 | NLK | 1.51306972 |
| 29 | MAP3K3 | 1.49593243 |
| 30 | TSSK6 | 1.46050779 |
| 31 | MAP2K6 | 1.40064088 |
| 32 | BTK | 1.39808763 |
| 33 | SIK2 | 1.39442963 |
| 34 | IRAK3 | 1.36265776 |
| 35 | LRRK2 | 1.35500294 |
| 36 | JAK3 | 1.34232472 |
| 37 | MAPK11 | 1.33936620 |
| 38 | IRAK4 | 1.31566500 |
| 39 | VRK1 | 1.31366466 |
| 40 | NEK2 | 1.31130043 |
| 41 | TBK1 | 1.30851087 |
| 42 | CCNB1 | 1.29701824 |
| 43 | CDC42BPA | 1.28751557 |
| 44 | TYK2 | 1.28224099 |
| 45 | PRKD2 | 1.27953351 |
| 46 | EIF2AK1 | 1.27910035 |
| 47 | TGFBR1 | 1.24438924 |
| 48 | TEC | 1.20431624 |
| 49 | KIT | 1.15850536 |
| 50 | MAP3K14 | 1.13454444 |
| 51 | SYK | 1.12621565 |
| 52 | ERN1 | 1.12402807 |
| 53 | RIPK4 | 1.09851907 |
| 54 | BRSK2 | 1.08408782 |
| 55 | EPHB1 | 1.06052291 |
| 56 | TAOK1 | 1.05248426 |
| 57 | ABL2 | 1.00445653 |
| 58 | TESK1 | 1.00245694 |
| 59 | BMX | 0.99881906 |
| 60 | TNK2 | 0.99542605 |
| 61 | CDC7 | 0.98345803 |
| 62 | GRK6 | 0.97592034 |
| 63 | MKNK2 | 0.96885813 |
| 64 | PASK | 0.96865785 |
| 65 | FLT3 | 0.96645267 |
| 66 | PDK3 | 0.96167434 |
| 67 | PDK4 | 0.96167434 |
| 68 | PDPK1 | 0.93459324 |
| 69 | MAP2K3 | 0.93256121 |
| 70 | MUSK | 0.93160000 |
| 71 | IKBKE | 0.91840133 |
| 72 | IRAK1 | 0.90717762 |
| 73 | RIPK1 | 0.90153715 |
| 74 | MAP3K1 | 0.88830527 |
| 75 | MAP3K11 | 0.88829875 |
| 76 | MST4 | 0.88745567 |
| 77 | MAPKAPK3 | 0.88237269 |
| 78 | SIK3 | 0.87141246 |
| 79 | ILK | 0.85659216 |
| 80 | MARK2 | 0.85057322 |
| 81 | LCK | 0.82471044 |
| 82 | MKNK1 | 0.80671608 |
| 83 | HIPK2 | 0.79633842 |
| 84 | BRSK1 | 0.79608240 |
| 85 | IKBKB | 0.79544185 |
| 86 | STK10 | 0.76827040 |
| 87 | PTK6 | 0.76421164 |
| 88 | CSK | 0.72380328 |
| 89 | CDK7 | 0.71746373 |
| 90 | ITK | 0.71254673 |
| 91 | SCYL2 | 0.70272637 |
| 92 | FES | 0.70012071 |
| 93 | PLK4 | 0.69306939 |
| 94 | DDR2 | 0.68549328 |
| 95 | PKN2 | 0.68228816 |
| 96 | MATK | 0.68060424 |
| 97 | CSF1R | 0.67700554 |
| 98 | BRAF | 0.67549331 |
| 99 | RPS6KB2 | 0.63320236 |
| 100 | CDK4 | 0.63314137 |
| 101 | PLK1 | 0.62858051 |
| 102 | ARAF | 0.62194609 |
| 103 | WNK4 | 0.59248033 |
| 104 | EIF2AK3 | 0.59243553 |
| 105 | AURKB | 0.59212236 |
| 106 | DYRK2 | 0.58942229 |
| 107 | MYLK | 0.57242326 |
| 108 | DAPK1 | 0.56628371 |
| 109 | MAP2K2 | 0.56339015 |
| 110 | RPS6KC1 | 0.54665134 |
| 111 | RPS6KL1 | 0.54665134 |
| 112 | RPS6KA2 | 0.54534503 |
| 113 | CAMKK1 | 0.54246450 |
| 114 | LYN | 0.54054322 |
| 115 | PIM1 | 0.52959964 |
| 116 | HCK | 0.52624875 |
| 117 | DAPK2 | 0.52467777 |
| 118 | ATR | 0.52332132 |
| 119 | MTOR | 0.52270883 |
| 120 | RPS6KA6 | 0.52183486 |
| 121 | IRAK2 | 0.51197556 |
| 122 | CSNK2A2 | 0.49094556 |
| 123 | PDK1 | 0.47736548 |
| 124 | MET | 0.47557854 |
| 125 | TGFBR2 | 0.46393427 |
| 126 | TTN | 0.46335855 |
| 127 | RAF1 | 0.45127889 |
| 128 | FGR | 0.43626414 |
| 129 | CSNK2A1 | 0.42408140 |
| 130 | MAP3K7 | 0.39832471 |
| 131 | TNIK | 0.39603080 |
| 132 | FGFR4 | 0.39488737 |
| 133 | PRKD1 | 0.38946254 |
| 134 | MAPKAPK2 | 0.38360077 |
| 135 | MAP3K6 | 0.38172002 |
| 136 | PTK2 | 0.37962229 |
| 137 | STK38 | 0.37507791 |
| 138 | MAP3K8 | 0.36706223 |
| 139 | CHUK | 0.36681112 |
| 140 | GRK7 | 0.36669582 |
| 141 | PTK2B | 0.36429918 |
| 142 | EEF2K | 0.35923717 |
| 143 | MAP3K13 | 0.35185056 |
| 144 | MAPK12 | 0.35061612 |
| 145 | MAP3K12 | 0.34736562 |
| 146 | PRKCI | 0.33582142 |
| 147 | LMTK2 | 0.33146974 |
| 148 | OBSCN | 0.32321665 |
| 149 | CAMKK2 | 0.31527471 |
| 150 | BLK | 0.31399519 |
| 151 | PAK4 | 0.31385054 |
| 152 | NEK1 | 0.31274312 |
| 153 | BRD4 | 0.30472285 |
| 154 | CAMK2G | 0.30156094 |
| 155 | DAPK3 | 0.29478394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.31400312 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.03246904 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.75929015 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.38020795 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.35892649 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.99993761 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.94976695 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.91186689 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.86079968 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54471423 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.46576047 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.42936447 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.42209844 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.41957925 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 2.31073065 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.20714374 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 2.19865447 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.10807235 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 2.07218177 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.95777535 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.90499841 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76534971 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.73819568 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.71228282 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.67304500 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65583580 |
| 27 | RNA degradation_Homo sapiens_hsa03018 | 1.64570715 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50531201 |
| 29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44799777 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43492219 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.42117332 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39998954 |
| 33 | Bladder cancer_Homo sapiens_hsa05219 | 1.39888397 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.37750211 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.37517587 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36801196 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.35425546 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35378749 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.34989495 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.33805133 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32910636 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.32755591 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.29814479 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.23616379 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22512358 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20251781 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.16279925 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16231989 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12423349 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.12404481 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11497726 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05155231 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.05029050 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04592527 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02052368 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.01920566 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99627956 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 0.94858948 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93293395 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.93060390 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93046901 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91909257 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91761867 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91318111 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89116053 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88093095 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87750907 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.85371323 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.82931577 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82674542 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.81339289 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.81259878 |
| 73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80271001 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79842459 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.76804793 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76658913 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75404403 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.73629932 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71829125 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70797408 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70612720 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68611615 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68058013 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65966408 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64949347 |
| 86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64539609 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64181413 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64028639 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63614764 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.62672282 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61996342 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.61623587 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61338245 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56639273 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56546464 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55479355 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.54929694 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.52925946 |
| 99 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52025007 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50757529 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49823599 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49225163 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48048477 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47837314 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46516013 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45667987 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45347226 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44725693 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43411901 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42707127 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42402673 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41716628 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41655089 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.41639298 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41341654 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41178417 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40781372 |
| 118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40212989 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39721189 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.38387566 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37117894 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.36846180 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36759513 |
| 124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33062487 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32552938 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32205392 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31927377 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31863491 |
| 129 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30807694 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30709160 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30251865 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29213832 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29074152 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28640677 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26819251 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26565007 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26329482 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25888222 |
| 139 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25386848 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.25146123 |
| 141 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24822828 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23534294 |
| 143 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20679526 |
| 144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20307593 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.19106408 |
| 146 | Tuberculosis_Homo sapiens_hsa05152 | 0.18243997 |

